If authorized, the Novavax shot would be the only protein-based Covid vaccine available in the U.S., which might appeal to some holdouts, some experts say.
by 90 percent in a group of more than 30,000 people in the U.S. and Mexico. But because the trial was conducted from December 2020 to February 2021, when the alpha variant of the coronavirus was dominant, it did not determine the vaccine’s efficacy against the virus’s omicron variant.
One advantage of the vaccine is that it can be stored in a regular refrigerator for up to six months, whereas mRNA vaccines must be kept at subzero temperatures, making them harder to transport. But some other experts questioned whether vaccine-hesitant people will think of Novavax any differently. The U.S. alreadyfrom December 2020 through mid-May — more than 11 percent of the doses distributed by the federal government, according to CDC data.
Österreich Neuesten Nachrichten, Österreich Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Novavax Covid-19 Vaccine Faces FDA Advisers’ ScrutinyThe outside panel of experts will vote on whether the shot should be authorized, after the agency found it effective but flagged a safety concern.
Weiterlesen »
FDA advisers meeting on Novavax, a latecomer in COVID-19 vaccine raceA federal advisory committee will vote on whether regulators should authorize a COVID-19 vaccine made by Novavax. From The New York Times.
Weiterlesen »
FDA advisory panel to consider approving fourth COVID-19 vaccine, this one from Maryland's NovavaxDevelopment of the vaccine, from Novavax, a Gaithersburg, Maryland-based company, was started at the same time as others in 2020, but the company struggled to produce its shot in large quantities.
Weiterlesen »
Novavax Covid Vaccine Clears Key Step on Path to FDA Authorization After Committee Endorses the ShotNovavax’s shot would be the fourth Covid vaccine authorized for use in the U.S. The shots use different technology than Pfizer and Moderna.
Weiterlesen »
FDA advisers back Novavax COVID-19 shots as new US optionNovavax shots are already used in Australia, Canada, parts of Europe and dozens of other countries. But U.S. clearance is a key hurdle for the Maryland-based company.
Weiterlesen »
FDA panel greenlights Novavax COVID-19 vaccineFDA's vaccine chief said another choice in the U.S. may entice at least some vaccine holdouts - whatever their reason - to consider rolling up their sleeves. FOX13
Weiterlesen »